Cybin IRL Limited
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder (NCT06793397) | Cybin IRL Limited | 2025-12-10 |
| Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) (NCT06605105) | Cybin IRL Limited | 2025-07-18 |
| "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder" (NCT06564818) | Cybin IRL Limited | 2024-12-17 |
| A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD) (NCT06051721) | Cybin IRL Limited | 2024-05-10 |
| A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder (NCT05385783) | Cybin IRL Limited | 2022-08-02 |
Track Cybin IRL Limited automatically
Every clearance here is in the API, with alerts when new ones post.